rs559979934

Variant names:

• chr2-201185838-C-G
• rs559979934
• NM_032977.4:c.61C>G

Your query was ambiguous. Multiple possible variants found:

• chr2-201185838-C-G
• chr2-201185838-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2 PP3

The NM_032977.4(CASP10):​c.61C>G​(p.Arg21Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R21C) has been classified as Likely benign.

• Frequency: Genomes: not found (cov: 32)
• Consequence: CASP10 NM_032977.4 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 1.92

Genes affected

CASP10 (HGNC:1500): (caspase 10) This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]

ACMG classification

Verdict is Uncertain_significance. Variant got 3 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.78

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CASP10	NM_032977.4	c.61C>G	p.Arg21Gly	missense_variant	Exon 2 of 10	ENST00000286186.11	NP_116759.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CASP10	ENST00000286186.11	c.61C>G	p.Arg21Gly	missense_variant	Exon 2 of 10	1	NM_032977.4	ENSP00000286186.6

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Uncertain	0.38
BayesDel_addAF	Pathogenic	0.22	D
BayesDel_noAF	Uncertain	0.080
CADD	Benign	21
DANN	Benign	0.97
DEOGEN2	Uncertain	0.63	.;.;D;.;.;.;.
Eigen	Benign	0.065
Eigen_PC	Benign	-0.14
FATHMM_MKL	Benign	0.18	N
LIST_S2	Uncertain	0.86	D;D;D;D;D;D;D
M_CAP	Benign	0.044	D
MetaRNN	Pathogenic	0.78	D;D;D;D;D;D;D
MetaSVM	Uncertain	-0.24	T
MutationAssessor	Uncertain	2.9	M;M;M;M;M;M;M
PrimateAI	Benign	0.39	T
PROVEAN	Uncertain	-3.8	D;D;D;D;D;D;D
REVEL	Uncertain	0.60
Sift	Uncertain	0.013	D;D;D;D;D;D;D
Sift4G	Uncertain	0.041	D;D;D;D;D;D;D
Polyphen		0.99	D;.;D;.;D;D;D
Vest4		0.46
MutPred		0.75		Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);Gain of ubiquitination at K17 (P = 0.0469);
MVP		0.91
MPC		0.45
ClinPred		0.79	D
GERP RS		3.2
Varity_R		0.66
gMVP		0.20

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs559979934; hg19: chr2-202050561;